Myron M. Levine

from Wikipedia, the free encyclopedia

Myron Max Levine (born February 11, 1944 in Riverdale , New York ) is an American medic.

Levine went to school in the Bronx and studied at City College of New York with a bachelor's degree in 1963. He studied medicine at the University of Virginia (Medical College) with a doctorate (MD) in 1967. He was still a student on research stays in Karachi and Costa Rica and spent semesters abroad in Jerusalem and Paris. He completed his specialist training in pediatrics at the Bronx Municipal Hospital and the Albert Einstein College of Medicine there. 1970 to 1972 he was a fellow in the field of infectious diseases at the University of Maryland , where he became an assistant professor in 1972, an associate professor in 1975 and a professor in 1982. From 1984 to 2014 he was head of the Geographic Medicine Department and the Tropical and Infectious Diseases Department in Pediatrics. He was founding director and until 2015 director of the Center for Vaccine Development (CVD) at the University of Virginia.

In 1974 he graduated from the London School of Hygiene and Tropical Medicine (DTPH). In 1987/88 he was a Fellow of the Sackler Institute for Advanced Studies at Tel Aviv University. He is also a regular visiting professor in Peru.

He led clinical trials for the typhoid vaccine Ty21a, was involved in the launch of a vaccine against Haemophilus influenzae in various developing countries, and in the development of the oral cholera vaccine Vaxchora (FDA approved in 2016). In addition to typhoid, paratyphoid and other salmonella pathogens for vaccine production, he also researched pathogens causing bacterial agitation with the aim of obtaining attenuated strains for vaccine development.

In 2017 he received the Maxwell Finland Award . In 1998 he received the Albert B. Sabin Gold Medal. He is a member of the National Academies' Institute of Medicine.

Web links

Individual evidence

  1. Birth and career data according to American Men and Women of Science , Thomson Gale 2004